Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (May 16, 2013)
-
Business Wire (May 15, 2013)
-
Business Wire (May 14, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (May 6, 2013)
To learn more about Seeking Alpha Pro, click here.
-
Plavix Patent Cliff Will Impact Bristol-Myers EarningsTrefis • Wed, Jan 23
-
at MarketWatch.com (Wed, 5:37PM)
-
at MarketWatch.com (Wed, 4:25PM)
-
at CNBC.com (Wed, 4:08PM)
-
at CNBC.com (Mon, 6:26PM)
-
Business Wire (May 16, 2013)
-
Business Wire (May 15, 2013)
-
at MarketWatch.com (May 15, 2013)
-
at CNBC.com (May 15, 2013)
-
Business Wire (May 14, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (May 6, 2013)
-
at CNBC.com (Apr 26, 2013)
-
at MarketWatch.com (Apr 25, 2013)
-
at MarketWatch.com (Apr 25, 2013)
-
at CNBC.com (Apr 25, 2013)
-
Business Wire (Apr 25, 2013)
-
at CNBC.com (Apr 24, 2013)
BMY vs. ETF Alternatives
Company Description
Bristol-Myers Squibb Company (which may be referred to as Bristol-Myers Squibb, BMS, the Company, we, our or us) was incorporated under the laws of the State of Delaware in August 1933 under the name Bristol-Myers Company, as successor to a New York business started in 1887. In 1989,... More




















